Prevalence of Kidney Disease among Pre-ART Patients with HIV Infection in Kunming and The Influencing Factors

Chongxi LI; Guangfeng YIN; Yushu ZHANG; Shanqun GU; Wei ZHANG; Jun LIU; Bo TIAN

doi:10.12259/j.issn.2095-610X.S20220208

Volume 43 Issue 2

Mar. 2022

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2022 > 43(2): 154-159

Rui CUN, Meiling CHEN. Efficacy and Clinical Application of Flunarizine Combined with Ginkgo damo in Treatment of Senile Vertigo[J]. Journal of Kunming Medical University, 2022, 43(7): 116-120. doi: 10.12259/j.issn.2095-610X.S20220703

Citation:

Chongxi LI, Guangfeng YIN, Yushu ZHANG, Shanqun GU, Wei ZHANG, Jun LIU, Bo TIAN. Prevalence of Kidney Disease among Pre-ART Patients with HIV Infection in Kunming and The Influencing Factors[J]. Journal of Kunming Medical University, 2022, 43(2): 154-159. doi: 10.12259/j.issn.2095-610X.S20220208

Citation:

PDF( 589 KB)

Prevalence of Kidney Disease among Pre-ART Patients with HIV Infection in Kunming and The Influencing Factors

doi: 10.12259/j.issn.2095-610X.S20220208

Chongxi LI^{1, 3},
Guangfeng YIN^{2, 3},
Yushu ZHANG^{2, 3},
Shanqun GU^{1, 3},
Wei ZHANG^{1, 3},
Jun LIU³,
Bo TIAN^{1, 3
,
,}

1.
Dept. of AIDS/STD，The Third People’s Hospital of Kunming
2.
Dept of Clinical Laboratory，The Third People’s Hospital of Kunming，Kunming Yunnan 650041
3.
Clinic Centrefor Infectious Diseases in Yunnan Province，Kunming Yunnan 650041，China

Received Date: 2021-12-23
Available Online: 2022-02-24
Publish Date: 2022-03-04

Abstract

Abstract

Objective To investigate the prevalence and characteristics of nephropathy in HIV infected patients before antiviral treatment, and to analyze the related factors of nephropathy before antiviral treatment. Methods Patients with HIV infection who visited the Third People’ s Hospital of Kunming from June 2019 to March 2021 were recruited and screened by urine analysis, serum creatinine, urine microalbumin-to-creatinine ratios, urinary α1 microglobulin, and renal ultrasound. And all patients were screened by triglyceride, total serum cholesterol, fasting plasma glucose test . Body mass index was measured.Demographic data , medical history of hypertension and diabetes were collected. SPSS17.0 was used for univariate analysis and logistic regression analysis. Results The mean age of 468 subjects was 43.42±14.66 years. The male to female ratio was 1.96. The mean body mass index was 21.73±3.76. Body mass index ≥25 accounted for 15% of all the subjects . Some patients smoked daily which accounted for 33.3% of all the subjects. Patients with hypertriglyceridemia, hypertension and diabetes accounted for 24.7%, 10.7%, 7.7% respectively. And 21.8% of patients were taking drugs which were not antiretroviral therapy. The detection rate of kidney disease in total of 468 cases was 20.7%. the CKD-EPI formula was used to calculate and estimate glomerular filtration rate （eGFR）. Patients with eGFR < 60 mL/min/1.73 m², 60～90 mL/min/1.73 m², ≥ 90 mL/min/1.73 m² accounted for 1.1%, 9.6%, 89.3% respectively. The positivity rate of urinary protein was 3.1%, which measured just only by urine analysis. The urinary microalbumin/creatinine ratio （ACR） ≥ 30 mg/gCr were occurred in 24/111 cases （21.6%）. The Urinary α1 microglobulin ≥ 12.5 mg/L were occurred in 71/111 cases （63.9%）. Multivariate analysis indicated the independent effects of the age ≥ 50 years （OR = 2.285, P = 0.002）, body mass index ≥25 （OR = 2.029, P = 0.025）, hypertension （OR = 2.334, P = 0.017）, diabetes （OR = 2.634, P = 0.014）, HIV viral load ≥1×10⁵ copies /mL （OR = 2.296, P = 0.002）, which significantly associated with kidney disease. Female is a protective factor for kidney disease in HIV infected persons before antiviral therapy. Conclusions The detection rate of kidney disease is high and mainly abnormal urinary protein in Kunming area.Gender, age, hypertension, diabetes, body mass index and HIV viral load are significantly associated with the kidney disease in HIV patients before antiviral treatment. When screening for kidney disease, it is recommended to fully evaluate the results with urine analysis, serum creatinine, renal ultrasound, urinary microalbumin/creatinine ratio, and urinary α1 microglobulin.
- HIV,
- Kidney disease,
- Risk factors,
- Urinary alpha1-microglobulin

FullText(HTML)

References(14)

References

[1]	Adih W K,Selik R M,Hu X. Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection,1996-2006[J]. J Int Assoc Physicians AIDS Care (Chic),2011,10(1):5-11. doi: 10.1177/1545109710384505
[2]	Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China:a cross-sectional survey[J]. Lancet,2012,379(9818):815-822. doi: 10.1016/S0140-6736(12)60033-6
[3]	Cao Y,Gong M,Han Y,et al. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in Mainland of China:a multicenter cross-sectional study[J]. Nephrology (Carlton),2013,18(4):307-312. doi: 10.1111/nep.12031
[4]	Stevens P E,Levin A. Kidney disease:improving global outcomes chronic kidney disease guideline development work group members. evaluation and management of chronic kidney disease:synopsis of the kidney disease:improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med,2013,158(11):825-830. doi: 10.7326/0003-4819-158-11-201306040-00007
[5]	Levey A S,Stevens L A,Schmid C H,et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med,2009,150(9):604-612. doi: 10.7326/0003-4819-150-9-200905050-00006
[6]	Shen Y,Wang J,Wang Z,et al. Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China[J]. Medicine (Baltimore),2015,94(48):1-8.
[7]	Jiang J,Qin X,Liu H,et al. An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi,China[J]. Sci Rep,2019,9(1):1-10.
[8]	徐小慧,单淑晴,时允,等. 云南省德宏州接受抗病毒治疗的HIV感染者高血压患病率及其影响因素[J]. 中国初级卫生保健,2020,34(4):48-51. doi: 10.3969/j.issn.1001-568X.2020.04.0015
[9]	Xu J F,Wang P C,Cheng F. Health related behaviors among HIV-infected people who are successfully linked to care:an institutional-based cross-sectional study[J]. Infect Dis Poverty,2020,9(1):1-9. doi: 10.1186/s40249-019-0617-6
[10]	眭维国,王磊. 代谢综合征与慢性肾脏病[J]. 国际泌尿系统杂志,2015,35(1):144-147. doi: 10.3760/cma.j.issn.1673-4416.2015.01.043
[11]	Wang Y,Sun B,Sheng L T,et al. Association between weight status,metabolic syndrome,and chronic kidney disease among middle-aged and elderly Chinese[J]. Nutr Metab Cardiovasc Dis,2020,30(11):2017-2026. doi: 10.1016/j.numecd.2020.06.025
[12]	Manaye G A,Abateneh D D,Niguse W. Chronic Kidney Disease and Associated Factors Among HIV/AIDS Patients on HAART in Ethiopia[J]. HIV AIDS (Auckl),2020,12:591-599.
[13]	Rosenberg A Z,Naicker S,Winkler C A,et al. HIV-associated nephropathies:epidemiology,pathology,mechanisms and treatment[J]. Nat Rev Nephrol,2015,11(3):150-160. doi: 10.1038/nrneph.2015.9
[14]	Ascher S B,Scherzer R,Estrella M M,et al. Kidney tubule health scores and their associations with incident CKD in women living with HIV[J]. HIV Med,2021,22(7):527-537. doi: 10.1111/hiv.13081

Relative Articles(20)

Relative Articles

[1]	Qianrong YANG, Xue CAO, Jiao YANG, Yanqiu ZHAO, Nan SHEN, Yajiao SUN. Status and Influencing Factors of Stigma in Lung Cancer Patients. Journal of Kunming Medical University, 2025, 46(1): 60-67. doi: 10.12259/j.issn.2095-610X.S20250108
[2]	Jiang ZHANG, Xijuan ZHAO, Jiang WU, Bingkun YANG, Ni YANG, Liping ZHOU. Analysis of Frailty Status and Influencing Factors in Lung Cancer Patients Undergoing Radiotherapy. Journal of Kunming Medical University, 2025, 46(2): 126-133. doi: 10.12259/j.issn.2095-610X.S20250218
[3]	Yihan LIU, Jun LIU, Yongmei JIN, Bo TIAN, Jinsong BAI. Risk Assessment and Analysis of Risk Factors for Cardiovascular Disease in HIV Antiviral Therapy Patients. Journal of Kunming Medical University, 2024, 45(10): 140-146. doi: 10.12259/j.issn.2095-610X.S20241022
[4]	Hongrui ZHAO, Xuelin XIANG, Zhongjie WANG, Yu XIA, Huadan WANG, Min MA, Liping HE. Analysis of Influencing Factors of Perceived Discrimination in HIV-infected Patients Treated with Antiviral Therapy. Journal of Kunming Medical University, 2024, 45(12): 88-93. doi: 10.12259/j.issn.2095-610X.S20241212
[5]	Xuelin XIANG, Hongrui ZHAO, Zhongjie WANG, Yu XIA, Min MA, Huadan WANG, Liping. HE. Social Support Status and Influencing Factors of HIV-infected Patients on Antiviral Therapy. Journal of Kunming Medical University, 2024, 45(9): 156-162. doi: 10.12259/j.issn.2095-610X.S20240924
[6]	Shuishui PAN, Jinsong BAI, Chongxi LI, Zhiqiong AI, Bo TIAN, Changlei MU, Yihan LIU, Jun LIU. Influencing Factors of Echocardiographic Abnormalities in HIV/AIDS Patients. Journal of Kunming Medical University, 2023, 44(4): 148-153. doi: 10.12259/j.issn.2095-610X.S20230422
[7]	Tingting YU, Dongling LI, Hongying WANG, Lihua LI, Dong PU, Kunli WU. Investigations on the Infection, Immunity and Drug Resistance of Newly-treated Cases of HIV in Kunming. Journal of Kunming Medical University, 2022, 43(1): 138-143. doi: 10.12259/j.issn.2095-610X.S20220133
[8]	Rui CAO, Chang XU, Xiaomei JIN, Jie DAI, Huichao CHEN, Lijuan DONG, Min YANG, Li YANG, Min CHEN. Analysis of Recent Infections Among HIV-1 Infected MSM in Kunming City from 2018 to 2020. Journal of Kunming Medical University, 2022, 43(8): 150-155. doi: 10.12259/j.issn.2095-610X.S20220825
[9]	Bin LIU, Xian-gang LI, Min ZHANG, Fang ZHOU, Ren-hua LIN, Jie YANG, Liang ZHANG, Xian-kun WANG, Ya-nan PAN. Main Influencing Factors of the Second Hospitalization of Patients with Coronary Heart Disease. Journal of Kunming Medical University, 2021, 42(6): 103-109. doi: 10.12259/j.issn.2095-610X.S20210618
[10]	Xiu-qing WANG, Xin-tian LONG, Yong MAO, Jie CHEN, Jia ZHOU, Tian-shu CHU, Song-mei WANG, Cheng-huan SUN, Chun-mi LAI, Qian ZHANG. Prevalence and Determinants of Hypertension in Senior Nu Ethnic Group. Journal of Kunming Medical University, 2021, 42(9): 40-45. doi: 10.12259/j.issn.2095-610X.S20210922
[11]	Xue-song HU, Li-yue CHEN, Shi-fu LI, Wen-bin DONG, Zi-qian HE, Shao-xin DONG, Shun-xiang LI. Influencing Factors Contributing to Insomnia Among Patients with Chronic Pain. Journal of Kunming Medical University, 2021, 42(2): 118-123. doi: 10.12259/j.issn.2095-610X.S20210207
[12]	Yong-rui YANG, Hai-wen LI, Zhi-rong ZHAO, Lu WANG, Ting JIA, Zhi-jian DONG, Xiao-fei LI, Ni-hong LU. Clinical Efficacy and Safety of Sofosbuvir and Vipatavir in the Treatment of Patients with Chronic Hepatitis C and HCV/HIV co-infection. Journal of Kunming Medical University, 2021, 42(7): 130-136. doi: 10.12259/j.issn.2095-610X.S20210722
[13]	Li Zhong Xi , Liu Jun , Bai Jing Song , Tian Bo , Yu Min , Gu Shan Qun . . Journal of Kunming Medical University, 2019, 40(01): 92-95.
[14]	Li Zhong Xi , Liu Jun , Guan Wei , He Rong , Zhang Wei , Bai Jing Song . . Journal of Kunming Medical University, 2019, 40(08): 102-106.
[15]	Ma Xiao Yan . The Depression Status and Influencing Factors for the Late Pregnancy Women. Journal of Kunming Medical University,
[16]	Zhou Gui , Shu Hai Yan , Luo Jiang Cun , Su Chao Min , Song Lie Xi , Liu Jia , Yang Jiao , Wang Hui Ling . Monitoring Results of HIV Infection in a Hospital in Chengdu. Journal of Kunming Medical University, 2016, 37(12): 122-126.
[17]	Lan Qing . . Journal of Kunming Medical University,
[18]	Li Xian Li . . Journal of Kunming Medical University,
[19]	Wang Juan Li . . Journal of Kunming Medical University,
[20]	He Li Ping . . Journal of Kunming Medical University,

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	陈安莉. 氟桂利嗪结合银杏达莫方案用于老年眩晕症患者的效果观察. 婚育与健康. 2025(04): 97-99 .
2.	迟凯扬，赵洪运. 镇肝熄风汤联合氟桂利嗪对肝阳上亢型眩晕患者临床疗效及血流动力学指标的影响. 临床医学工程. 2024(11): 1347-1348 .
3.	金赢政，井睿智，李金江. 天麻钩藤饮联合针灸治疗后循环缺血性眩晕临床研究. 新中医. 2023(22): 53-58 .
4.	任淑珍，陈友芹，刘艳丽. 耳后注射倍他司汀联合氟桂利嗪治疗外周性眩晕的临床效果及对血流速度的影响. 实用中西医结合临床. 2023(20): 102-105 .
5.	王凌燕，曹国军，龚甜，周诗晶. 银杏达莫注射液联合前列地尔治疗椎-基底动脉供血不足眩晕症患者的疗效及对血流动力学的影响. 湖南师范大学学报(医学版). 2023(06): 92-96 .